We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
PUT
Stem
STEM
$44.3M
| $1.03M | 0.03% |
+1,935
| New | +$1.24M |
|
602
PUT
Regenxbio
RGNX
$616M
| $1.02M | 0.03% |
+30,000
| New | +$1.28M |
|
603
Blackstone
BX
$104B
| $1.02M | 0.03% |
+13,700
| New | +$946K |
|
|
ME
604
CALL
DELISTED
23andMe Holding Co
ME
| $1.02M | 0.03% |
+5,000
| New | +$1.22M |
|
605
CALL
APA Corp
APA
$13B
| $1.01M | 0.03% |
56,500
+31,500
| +126% | +$575K |
|
606
CALL
Ambarella
AMBA
$3.04B
| $1M | 0.03% |
10,000
-497,400
| -98% | -$54.1M |
|
607
Pinduoduo
PDD
$126B
| $1M | 0.03% |
7,500
+5,000
| +200% | +$844K |
|
608
CALL
CarParts.com
PRTS
$42.6M
| $1M | 0.03% |
7,000
+5,000
| +250% | +$808K |
|
|
RETA
609
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $997K | 0.02% |
+10,000
| New | +$1.17M |
|
|
CANO
610
CALL
DELISTED
Cano Health, Inc.
CANO
| $994K | 0.02% |
+750
| New | +$1.06M |
|
611
Gilead Sciences
GILD
$165B
| $976K | 0.02% |
15,100
+4,100
| +37% | +$264K |
|
612
CALL
Virtu Financial
VIRT
$5.04B
| $975K | 0.02% |
+31,400
| New | +$866K |
|
613
Vertex Pharmaceuticals
VRTX
$123B
| $967K | 0.02% |
4,500
-500
| -10% | -$110K |
|
614
CALL
Criteo S.A. Ordinary Shares
CRTO
$1.14B
| $965K | 0.02% |
+27,800
| New | +$764K |
|
615
PUT
Apollo Global Management
APO
$69B
| $964K | 0.02% |
+20,500
| New | +$997K |
|
|
STKL
616
DELISTED
SunOpta
STKL
| $960K | 0.02% |
+65,000
| New | +$931K |
|
|
BLUE
617
PUT
DELISTED
bluebird bio
BLUE
| $959K | 0.02% |
+2,455
| New | +$1.21M |
|
|
LSI
618
DELISTED
Life Storage, Inc.
LSI
| $945K | 0.02% |
11,000
-9,250
| -46% | -$769K |
|
|
DBD
619
DELISTED
Diebold Nixdorf Incorporated
DBD
| $940K | 0.02% |
66,500
+16,500
| +33% | +$227K |
|
620
Celularity
CELU
$19.4M
| $936K | 0.02% |
+9,282
| New | +$951K |
|
621
CALL
Travere Therapeutics
TVTX
$5.17B
| $936K | 0.02% |
+37,500
| New | +$1.04M |
|
622
PUT
Autohome
ATHM
$2.62B
| $933K | 0.02% |
+10,000
| New | +$1.11M |
|
623
Palantir
PLTR
$295B
| $932K | 0.02% |
+40,000
| New | +$1.1M |
|
624
PUT
Scorpio Tankers
STNG
$3.91B
| $923K | 0.02% |
50,000
| – | – |
|
625
Invesco Solar ETF
TAN
$1.37B
| $918K | 0.02% |
+10,000
| New | +$1.05M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.